Impaired cardiac autonomic response in lung transplant patients: A retrospective cohort study

Clin Transplant. 2019 Jul;33(7):e13612. doi: 10.1111/ctr.13612. Epub 2019 Jun 20.

Abstract

Background: Cardiac autonomic dysfunction (AD) is associated with adverse prognosis in lung disease; however, its implications in lung transplantation have not been previously described. This study evaluated the prevalence of AD in lung transplant (LTx) candidates, its determinants, prognostic implications, and prevalence post-transplant.

Methods: Retrospective one-year study of 103 LTx candidates with AD assessed using heart rate (HR) from the six-minute walk test (6MWT). Impaired chronotropic response index (CRI) was defined as <80% age-adjusted HR during 6MWT. Abnormal HR recovery (HRR) was categorized as reduction in HR ≤ 12 beats/minute after the first minute of 6MWT cessation.

Results: Abnormal CRI and HRR were observed in 94% and 76% of patients, respectively. A lower CRI was associated with obstructive lung disease and lower estimated aerobic capacity. CRI was independently associated with 6MW distance [12 m per 10% CRI, P = 0.03], but not with post-transplant cardiovascular events, hospital stay, or one-year mortality. At 3 months post-transplant, no improvement was observed in CRI (99%, n = 66/67, P = 0.25) or HRR (88%, n = 36/41, P = 0.12).

Conclusion: Cardiac AD was prevalent in LTx candidates and recipients, with chronotropic incompetence a modest contributor to exercise intolerance pretransplant. Further study may help determine whether direct autonomic measures such as HR variability may be more prognostic of LTx outcomes.

Keywords: autonomic function; chronotropic incompetence; heart rate recovery; lung transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autonomic Nervous System Diseases / etiology
  • Autonomic Nervous System Diseases / pathology*
  • Autonomic Nervous System Diseases / therapy
  • Exercise Therapy
  • Female
  • Follow-Up Studies
  • Heart Rate
  • Humans
  • Lung Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Factors

Grants and funding